Medannex Ltd (Edinburgh) today announced the presentation of the first clinical data from the ongoing Phase 1b
study of MDX-124, at the European Society for Medical Oncology (ESMO) Congress 2025.
Read the full story here.
20 October 2025
The voice of Scotland’s life sciences industries
Members’ area
20 October 2025
Medannex Ltd (Edinburgh) today announced the presentation of the first clinical data from the ongoing Phase 1b
study of MDX-124, at the European Society for Medical Oncology (ESMO) Congress 2025.
Read the full story here.